BTG PLC (BTG.L)

BTG.L on London Stock Exchange

700.00GBp
30 Sep 2014
Price Change (% chg)

25.50p (+3.78%)
Prev Close
674.50p
Open
675.50p
Day's High
702.50p
Day's Low
674.50p
Volume
909,323
Avg. Vol
479,898
52-wk High
702.50p
52-wk Low
365.30p

BTG.L

Chart for BTG.L

About

BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology. Its focus within Specialty Pharmaceuticals is on antidote products that are used within hospitals. Its interventional medicine products are... (more)

Overall

Beta: 0.34
Market Cap (Mil.): £2,446.00
Shares Outstanding (Mil.): 362.64
Dividend: --
Yield (%): --

Financials

  BTG.L Industry Sector
P/E (TTM): 98.35 33.26 33.98
EPS (TTM): 0.07 -- --
ROI: 4.41 18.14 17.39
ROE: 5.04 18.84 18.24
Search Stocks

BRIEF-BTG receives FDA nod for pulmonary embolism treatment

* Ekosonic endovascular system receives FDA clearance for treatment of pulmonary embolism in USA Source text for Eikon: Further company coverage:

23 May 2014

BRIEF-BTG full-year pretax profit rises 38 pct

* FY pretax profit 33.3 million stg versus 24.1 million stg year ago

20 May 2014

BRIEF-BTG sees year revenue around top end of guidance range

LONDON, April 3 - BTG plc update for the year ended 31 March 2014:

03 Apr 2014

Earnings vs. Estimates

Search Stocks